Agios Pharmaceuticals
AGIO
#5116
Rank
A$2.43 B
Marketcap
A$40.91
Share price
-3.35%
Change (1 day)
-17.85%
Change (1 year)

Earnings for Agios Pharmaceuticals (AGIO)

Earnings in 2026 (TTM): -A$0.72 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's current earnings are A$66.04 Million. In 2025 the company made an earning of -A$0.66 Billion a decrease over its 2024 earnings that were of -A$0.6 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agios Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.72 Billion8.13%
2025 -A$0.66 Billion10.9%
2024 -A$0.6 Billion8.75%
2023 -A$0.55 Billion0.63%
2022 -A$0.55 Billion2.81%
2021 -A$0.53 Billion10.58%
2020 -A$0.48 Billion-18.41%
2019 -A$0.59 Billion15.72%
2018 -A$0.51 Billion12.99%
2017 -A$0.45 Billion59.61%
2016 -A$0.28 Billion69.32%
2015 -A$0.17 Billion119.28%
2014 -A$75.34 Million39.22%
2013 -A$54.11 Million69.1%
2012 -A$32 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$14.73 B-2,327.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$43.31 B-6,645.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$13.93 B-2,205.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
-A$0.2 Billion-70.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$1.39 B-310.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.53 B-181.09%๐Ÿ‡บ๐Ÿ‡ธ USA